Recombinant human TNF receptor II fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human TNF receptor II fusion protein, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout [NA]